HealthEquity, Inc. (HQY) Stock: Price, Forecast & Analyst Target
HealthEquity, Inc. (HQY) — MoonshotScore 91/100 (Exceptional band), calculated Oct 4, 2026. Price $90.04 (+0.75%), as of the Oct 2, 2026 trading session; market cap $7.53B. Expected results Dec 2, 2026.
Educational signal · not a buy or sell recommendation · How to read this
Market value / cash and short-term investments: 29.41× (market value Oct 2, 2026; cash Jul 31, 2026) · expected results Dec 2, 2026
HealthEquity, Inc. · HQY · NASDAQ · Healthcare · Medical - Healthcare Information Services
Research dated 2026-09-13: HealthEquity administers tax-advantaged health accounts and related benefits through a cloud platform, while also earning from payment activity and the economics of HSA cash. Its case depends on whether expanding account economics and operating leverage can keep lifting profit and cash generation while debt remains well above cash.
Price as of Oct 2, 2026
Key Statistics
MoonshotScore v2 · HealthEquity (HQY)
ExceptionalWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Elite quality, a strong balance sheet and elite growth, with no real weak spot — fairly priced, so not a bargain entry. Business Quality: Elite; Financial Safety: Sound; Valuation: Full; Growth Durability: Compounding; Momentum: Rising.
- quarterly revenue $351M (Q2 FY2027, quarter ended Jul 2026)
- EPS beat 7 of 8
- Altman Z 4.46 · Piotroski F 8
Helping: business quality, balance-sheet strength, durable growth, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 90 | Exceptional | |
| 90 | Exceptional | |
| 90 | Exceptional | |
| 90 | Exceptional | |
| 91 | Exceptional | |
| 91 | Exceptional |
The score was 91 in the stored Oct 3, 2026 snapshot and remains 91 in the current publication computed Oct 4, 2026 (0); the largest pillar moves were Momentum +1; the pillar moves offset under the sector-relative weighting, so the headline score is unchanged. This current publication is not yet represented in the immutable snapshot archive.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $90.04 | |
| Change on the day | +0.75% | |
| 52-week range | $72.76 – $107.62 | |
| Market capitalisation | $7.53B | |
| Price / earnings (trailing) | 32.16 | |
| Shares traded on the day | 834.5K | |
| Beta (volatility vs the S&P 500) | 0.23 |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings call · management outlook
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Management outlook
For fiscal 2027, we now expect revenue between $1.411 billion and $1.421 billion.
James Lucania · Statement from
Second, as a reminder of the cadence we set last year, we expect to publish year-end sales metrics after the conclusion of our January 31st fiscal year, and we will provide fiscal 2028 guidance when we report our fiscal 2027 year-end financial results.
Richard Putnam · Statement from
Statement dates identify the earnings call, not a deadline. Management expectations and provider estimates can change.
Read management statementsCouncil Score · weighted blend of 2 available disciplines
Council score for HealthEquity (HQY): Bullish Lean
74/100 · ASome lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.
5-Factor Breakdown
Legends Council
4 lenses, 4 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Oct 4, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
One of these lenses reads this company less favourably than the MoonshotScore does: Klarman-style lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Oct 4, 2026, except a card that shows its own read date.
Watch the HQY film — every key number, told as a short cinematic story
~2 min · open the film
What is HealthEquity (HQY), and what does it report?
Short answer · as of
HealthEquity is not a healthcare provider. It supplies the account infrastructure through which consumers and employers manage health savings, flexible spending, reimbursement arrangements, continuation coverage and commuter benefits, with tools for bill payment, cost comparison and investing.
Research dated 2026-09-13.
HealthEquity is not a healthcare provider. It supplies the account infrastructure through which consumers and employers manage health savings, flexible spending, reimbursement arrangements, continuation coverage and commuter benefits, with tools for bill payment, cost comparison and investing.
Reported revenue blends service fees, credit and debit card activity, and other financial services. Those lines measure administration, platform usage, payment activity and financial economics rather than the volume of medical care delivered.
What do the latest results show for HealthEquity (HQY)?
Short answer · as of
The most recent reported quarter, Q2 FY2027, carried revenue of $351M.
Research dated 2026-09-13.
Revenue eased from the preceding quarter but remained above the comparable prior period. Operating profit, net income and diluted earnings also stepped down sequentially while staying ahead of their prior-period counterparts.
Across the annual series, revenue advanced throughout the reported span as losses gave way to rising profits, even while research and development spending increased. The recent earnings record also shows repeated revenue and earnings beats against estimates.
Management currently expects further annual revenue expansion and explicitly includes the average yield on HSA cash among its outlook assumptions. That yield is a stated business sensitivity, not a demonstrated explanation for every quarterly movement.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $350.73M Jul 31, 2026
- Latest quarter · R&D
- $73.92M Jul 31, 2026
- Latest quarter · SG&A
- $58.08M Jul 31, 2026
- Latest quarter · FMP standardized operating result
- $98.69M Jul 31, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Jul 31, 2026 | $350.73M | $73.92M | $58.08M | $98.69M |
| Apr 30, 2026 | $354.64M | $67.77M | $57.96M | $102.95M |
| Jan 31, 2026 | $334.59M | $70.35M | $171.43M | $67.37M |
| Oct 31, 2025 | $322.16M | $65.92M | $55.29M | $79.85M |
USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $350.70M Aug 27, 2026
- Latest report · revenue estimate
- $349.22M Aug 27, 2026
- Latest report · revenue vs estimate
- Above estimate Aug 27, 2026
- Latest report · EPS vs estimate
- Above estimate Aug 27, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Aug 27, 2026 | $350.70M | $349.22M | $1.2400 | $1.1900 |
| May 28, 2026 | $354.64M | $352.02M | $1.2400 | $1.1100 |
| Mar 17, 2026 | $334.60M | $332.32M | $0.9500 | $0.8900 |
| Dec 3, 2025 | $322.20M | $320.63M | $1.0100 | $0.9120 |
Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2027 | $351M | $66M | $0.78 (diluted) |
| Q1 FY2027 | $355M | $69M | $0.82 (diluted) |
| Q4 FY2026 | $335M | $50M | $0.58 (diluted) |
| Q3 FY2026 | $322M | $52M | $0.59 (diluted) |
What are the financial strengths and risks for HealthEquity (HQY)?
Short answer
Cash and short-term investments were $256.00M at the Jul 31, 2026 balance-sheet date. Operating cash flow was $136.16M for the quarter ended Jul 31, 2026, meaning operations generated cash. These figures do not establish a cash runway.
Research dated 2026-09-13.
Operating cash flow was positive in every reported quarter and strengthened in the latest period, while recent capital expenditure was modest. That cash generation supplies internal capacity for growth initiatives and capital allocation.
Debt substantially exceeds cash and short-term investments, and the cash balance has declined across the reported window despite positive operating cash flow. Supportive liquidity ratios and financial-quality screens reduce immediate strain but do not remove the balance-sheet tradeoffs.
A weaker yield on HSA cash could pressure an earnings mechanism that management explicitly incorporates into its outlook. Growth spending, repurchases, revolver reduction and portfolio acquisitions must also compete for the same financial capacity.
How much cash does the business generate or use?
Quarterly operating cash flow shows cash generated or used by operations.
- Latest quarter · operating cash flow
- $136.16M Jul 31, 2026
- Previous quarter · operating cash flow
- $97.53M Apr 30, 2026
| Period end | Operating cash flow | Capital expenditure (reported) |
|---|---|---|
| Jul 31, 2026 | $136.16M | −$980,000 |
| Apr 30, 2026 | $97.53M | −$360,000 |
| Jan 31, 2026 | $117.92M | −$16.38M |
| Oct 31, 2025 | $138.57M | −$780,000 |
Operating cash-flow bars share one scale and show magnitude; negative values mean cash used.
USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway.
What should you watch next at HealthEquity (HQY)?
Short answer · as of
The next earnings report is expected on Dec 2, 2026.
Research dated 2026-09-13.
The scheduled earnings report carries a revenue expectation slightly below the latest result. Watch whether revenue stabilizes, operating profit resumes its advance and operating cash flow remains firm; recent estimate beats make the comparison with expectations relevant, but the underlying direction matters more than another beat.
Beyond the headline result, watch the realized yield on HSA cash, the year-end sales metrics when published, and the allocation of cash among repurchases, revolver reduction and portfolio acquisitions. Management has identified each of these as an upcoming operating or capital-allocation consideration.
What management is planning
Management expectations, not completed milestones or guarantees. Selected verbatim excerpts; dates follow the transcript provider.
For fiscal 2027, we now expect revenue between $1.411 billion and $1.421 billion.
James Lucania ·
Second, as a reminder of the cadence we set last year, we expect to publish year-end sales metrics after the conclusion of our January 31st fiscal year, and we will provide fiscal 2028 guidance when we report our fiscal 2027 year-end financial results.
Richard Putnam ·
We now expect average yield on HSA cash to be between 3.85% and 3.9% during fiscal 2027.
James Lucania ·
Our guidance also reflects funding growth initiatives in the second half of the year, expected capital allocation activity, including additional share repurchase under the expanded authorization, and potential reductions in revolver borrowings during the year. With continued strong cash flow and revolver availability, we expect to maintain ample capacity for portfolio acquisitions should attractive opportunities become available.
James Lucania ·
How does HealthEquity compare with its peers?
Short answer
HealthEquity's score ranks 6th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-13.
HealthEquity combines benefits administration with payment and custodial-financial economics. Service revenue sits beside card revenue and other financial services, while the platform spans health savings, flexible spending, reimbursement arrangements, continuation coverage and commuter benefits.
That mix makes account balances, HSA cash yield, member payment activity and administration demand relevant at the same time. A comparison based only on benefits-software fees would therefore miss material parts of how HealthEquity earns revenue.
| Company | Price | Market value | Score |
|---|---|---|---|
| $75.60 Oct 2, 2026 | $10.2B | 96 5-pillar Oct 4, 2026 | |
| $317.55 Oct 2, 2026 | $12.5B | 95 5-pillar Oct 4, 2026 | |
| $27.93 Oct 2, 2026 | $5.22B | 94 5-pillar Oct 4, 2026 | |
| $97.67 Oct 2, 2026 | $7.56B | 93 5-pillar Oct 4, 2026 | |
| $25.23 Oct 2, 2026 | $1.98B | 92 5-pillar Oct 4, 2026 | |
| HealthEquity (HQY) — this page | $90.04 | $7.53B | 91 |
| $60.25 Oct 2, 2026 | $11.8B | 83 5-pillar Oct 4, 2026 | |
| $178.69 Oct 2, 2026 | $11.5B | 76 5-pillar Oct 4, 2026 | |
| $189.54 Oct 2, 2026 | $9.89B | 70 5-pillar Oct 4, 2026 | |
| $64.29 Oct 2, 2026 | $29.0B | 61 5-pillar Oct 4, 2026 | |
| $93.50 Oct 2, 2026 | $11.9B | 39 5-pillar Oct 4, 2026 | |
| $20.30 Oct 2, 2026 | $2.56B | 35 5-pillar Oct 4, 2026 | |
| $49.32 Oct 2, 2026 | $4.25B | 32 5-pillar Oct 4, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $105.00 – $142.00
- Consensus target
- $115.29
- Median target
- $111.00
Consensus record · Captured .
Measured against a quoted price of $90.04 (as of Oct 2, 2026).
Insider activity
Form 4 records via FMP · Of the newest 60 records, those within the last 180 days, newest dated Sep 17, 2026
- Transactions
- 26
- Identified insiders
- 14
- Purchases
- 0
- Sales
- 7
- Other transactions
- 19
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
- Reporting holders
- 508 Period end Jun 30, 2026
- Previous quarter · holders
- 494 Prior to period end Jun 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Blackrock, INC. | 11,277,914 |
| Wasatch Advisors LP | 7,960,735 |
| Morgan Stanley | 4,547,219 |
| Vanguard Portfolio Management LLC | 4,057,643 |
| Vanguard Capital Management LLC | 3,640,776 |
Quarterly filings lag the period end. Holder rows are names in the provider snapshot, not a verified ranking; individual filing dates are not supplied. Related managers may appear separately, so these positions are not summed. Holder snapshot as of Jun 30, 2026.
What has been published about HealthEquity (HQY)?
HQY Healthcare Stock FAQ
Research dated 2026-09-13; the answers below are from that research, and the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
How does Advisor extend HealthEquity’s HSA platform?
Advisor adds automated online guidance and investment choices to account administration, allowing members to manage and grow health savings within the broader platform.
Why does HealthEquity disclose the yield on HSA cash?
Management treats the yield earned on HSA cash as an outlook assumption, showing that account balances contribute financial economics alongside service and card revenue. A lower realized yield would weaken that contribution unless offset elsewhere.
How do COBRA and commuter benefits fit into HealthEquity?
COBRA continuation services and pretax commuter programs broaden HealthEquity beyond health savings accounts. They place additional employer-benefit administration on the same general platform and distribution network.
Can HealthEquity fund buybacks while reducing its revolver?
Positive operating cash flow provides capacity for capital allocation, and management expects repurchases and possible revolver reductions. Debt remains well above cash, however, so buybacks, repayment, growth spending and acquisitions remain competing uses of funds.
What is the HQY stock price today?
The last price recorded on this page for HealthEquity, Inc. (HQY) is $90.04, as of the Oct 2, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the HQY price target?
The analyst consensus price target for HealthEquity, Inc. (HQY) is $115.29 (range $105.00 to $142.00, median $111.00), per FMP data captured Oct 4, 2026. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are shown with each answer. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (82 figures)
The 82 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
OFFICIAL — 2 facts from SEC filings and earnings calls
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
prod.outlook | Management outlook — call excerpts | James Lucania (Aug 27, 2026): For fiscal 2027, we now expect revenue between $1.411 billion and $1.421 billion. Richard Putnam (Aug 27, 2026): Second, as a reminder of the cadence we set last year, we expect to publish year-end sales metrics after the conclusion of our January 31st fiscal year, and we will provide fiscal 2028 guidance when we report our fiscal 2027 year-end financial results. James Lucania (Aug 27, 2026): We now expect average yield on HSA cash to be between 3.85% and 3.9% during fiscal 2027. James Lucania (Aug 27, 2026): Our guidance also reflects funding growth initiatives in the second half of the year, expected capital allocation activity, including additional share repurchase under the expanded authorization, and potential reductions in revolver borrowings during the year. With continued strong cash flow and revolver availability, we expect to maintain ample capacity for portfolio acquisitions should attractive opportunities become available. | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) — Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | |
id.hq | SEC filing business address | 15 West Scenic Pointe Drive, Suite 100, Draper, UT, 84020 | OFFICIAL | SEC EDGAR filer business address — The SEC filer business address. Our market-data provider separately lists "15 West Scenic Pointe Drive, Draper, UT, 84020, US". |
FMP — 72 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.next | Next earnings date | Dec 2, 2026 | FMP | Financial Modeling Prep (FMP) earnings calendar — The date is our provider's estimate until the company confirms it. | |
px.last | Latest provided price | $90.04 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-04T21:04:46.148Z. | |
px.change | Change on the day | +0.75% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalisation | $7.53B | FMP | Financial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:00.000Z. Captured from FMP at 2026-10-04T21:04:44.619Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
px.change_abs | Change on the day, in dollars | +$0.67 | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q2 FY2027 | $351M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
px.pe | Price / earnings (trailing) | 32.16 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 834.5K | FMP | Financial Modeling Prep (FMP) · quote | |
px.beta | Beta | 0.23 | FMP | Financial Modeling Prep (FMP) company profile | |
id.ceo | Chief executive | Scott R. Cutler | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
id.founder | Founder named in the filing | Stephen D. Neeleman — Founder & Vice Chairman | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
id.employees | Employees | 2,814 | FMP | Financial Modeling Prep (FMP) employee count, from the company's filing | |
fin.annual | Revenue and net result by fiscal year | 5 fiscal years, FY2022 through FY2026: FY2022 revenue $756.56M, net result −$44.29M; FY2023 revenue $861.75M, net result −$26.14M; FY2024 revenue $999.59M, net result $55.71M; FY2025 revenue $1.20B, net result $96.70M; FY2026 revenue $1.31B, net result $215.20M | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements | |
fin.rev_mix | Reported revenue segments | Service $485.02M · Credit and Debit Card $191.61M · Financial Service, Other $636.80M | FMP | Financial Modeling Prep (FMP) revenue segmentation, from the company's 10-K | |
fin.gross_margin | Gross margin (trailing twelve months) | 71.2% | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero. | |
fin.q_table.depth.2026-07-31.revenue_k | Revenue — period end 2026-07-31 | $350.73M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-07-31.rd_k | R&D — period end 2026-07-31 | $73.92M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-07-31.sga_k | SG&A — period end 2026-07-31 | $58.08M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-07-31.operating_result_k | FMP standardized operating result — period end 2026-07-31 | $98.69M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-04-30.revenue_k | Revenue — period end 2026-04-30 | $354.64M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-04-30.rd_k | R&D — period end 2026-04-30 | $67.77M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-04-30.sga_k | SG&A — period end 2026-04-30 | $57.96M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-04-30.operating_result_k | FMP standardized operating result — period end 2026-04-30 | $102.95M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-01-31.revenue_k | Revenue — period end 2026-01-31 | $334.59M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-01-31.rd_k | R&D — period end 2026-01-31 | $70.35M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-01-31.sga_k | SG&A — period end 2026-01-31 | $171.43M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-01-31.operating_result_k | FMP standardized operating result — period end 2026-01-31 | $67.37M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-10-31.revenue_k | Revenue — period end 2025-10-31 | $322.16M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-10-31.rd_k | R&D — period end 2025-10-31 | $65.92M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-10-31.sga_k | SG&A — period end 2025-10-31 | $55.29M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-10-31.operating_result_k | FMP standardized operating result — period end 2025-10-31 | $79.85M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
earn.history.depth.2026-08-27.revenue_actual | Revenue · reported — report date 2026-08-27 | $350.70M | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-08-27.revenue_estimated | Revenue · estimate — report date 2026-08-27 | $349.22M | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-08-27.eps_actual | EPS · reported — report date 2026-08-27 | $1.2400 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-08-27.eps_estimated | EPS · estimate — report date 2026-08-27 | $1.1900 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-05-28.revenue_actual | Revenue · reported — report date 2026-05-28 | $354.64M | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-05-28.revenue_estimated | Revenue · estimate — report date 2026-05-28 | $352.02M | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-05-28.eps_actual | EPS · reported — report date 2026-05-28 | $1.2400 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-05-28.eps_estimated | EPS · estimate — report date 2026-05-28 | $1.1100 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-03-17.revenue_actual | Revenue · reported — report date 2026-03-17 | $334.60M | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-03-17.revenue_estimated | Revenue · estimate — report date 2026-03-17 | $332.32M | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-03-17.eps_actual | EPS · reported — report date 2026-03-17 | $0.9500 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-03-17.eps_estimated | EPS · estimate — report date 2026-03-17 | $0.8900 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-12-03.revenue_actual | Revenue · reported — report date 2025-12-03 | $322.20M | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-12-03.revenue_estimated | Revenue · estimate — report date 2025-12-03 | $320.63M | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-12-03.eps_actual | EPS · reported — report date 2025-12-03 | $1.0100 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-12-03.eps_estimated | EPS · estimate — report date 2025-12-03 | $0.9120 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2027 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
fin.cash_investments | Cash and short-term investments | $256.00M | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. | |
fin.opcf_latest | Latest-quarter operating cash flow | $136.16M | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Period end: 2026-07-31. Negative operating cash flow means cash used. This figure is not a cash-runway estimate. | |
fin.long_term_investments | Long-term investments (classification unverified) | $0.00 | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | |
fin.total_debt | Total debt | $971.02M | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | |
fin.price_to_book | Price to book value | 3.75× | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero. | |
fin.opcf.depth.2026-07-31.operating_cash_flow_m | Operating cash flow — period end 2026-07-31 | $136.16M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-04-30.operating_cash_flow_m | Operating cash flow — period end 2026-04-30 | $97.53M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-07-31.capex_m | Capital expenditure (reported) — period end 2026-07-31 | −$980,000 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-04-30.capex_m | Capital expenditure (reported) — period end 2026-04-30 | −$360,000 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-01-31.operating_cash_flow_m | Operating cash flow — period end 2026-01-31 | $117.92M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-01-31.capex_m | Capital expenditure (reported) — period end 2026-01-31 | −$16.38M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-10-31.operating_cash_flow_m | Operating cash flow — period end 2025-10-31 | $138.57M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-10-31.capex_m | Capital expenditure (reported) — period end 2025-10-31 | −$780,000 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
earn.pt_range | Analyst price target, low to high | $105.00 – $142.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied | |
earn.pt_consensus | Consensus analyst price target | $115.29 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied | |
earn.pt_median | Median analyst price target | $111.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied | |
own.insiders | Insider transactions via FMP | 26 transactions · 0 purchases, 7 sales, 19 other transactions · 14 identified insiders · of the newest 60 records, those within the last 180 days, newest dated Sep 17, 2026 | FMP | Financial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent. | |
own.institutions.depth.holders | Reporting holders | 508 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.holders_previous_quarter | Previous quarter · holders | 494 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.top_holders.depth.holder_0.shares | Blackrock, INC. — shares in provider snapshot | 11,277,914 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_1.shares | Wasatch Advisors LP — shares in provider snapshot | 7,960,735 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_2.shares | Morgan Stanley — shares in provider snapshot | 4,547,219 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_3.shares | Vanguard Portfolio Management LLC — shares in provider snapshot | 4,057,643 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_4.shares | Vanguard Capital Management LLC — shares in provider snapshot | 3,640,776 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. |
UNRECORDED — 3 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.history | Reported versus estimated, recent quarters | EPS beat 7 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-09-08 · Expired observation | |
fin.scores | Distress and quality screens | Altman Z 4.46 · Piotroski F 8 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-04 | |
px.range52 | 52-week range | $72.76 – $107.62 | UNRECORDED | Stored company-profile observation — Captured 2026-10-04 |
COMPUTED — 3 facts from our arithmetic, formula restated
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
fin.mcap_to_cash | Market value per dollar of cash and short-term investments | 29.41× | — | COMPUTED | Computed on this page from the figures above — The market capitalisation printed on this page divided by cash and short-term investments of $256.00M at Jul 31, 2026. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. Market cap record date: 2026-10-02. Balance-sheet reference date: 2026-07-31. The inputs do not establish a single common source date for this ratio. |
earn.history.depth.2026-08-27.revenue_actual.comparison | Latest report · revenue vs estimate | Above estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported revenue ($350.70M) with the recorded estimate ($349.22M) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
earn.history.depth.2026-08-27.eps_actual.comparison | Latest report · EPS vs estimate | Above estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported EPS ($1.2400) with the recorded estimate ($1.1900) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
OURS — 2 facts from Stock Expert AI's own score and rank
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
ours.moonshot | MoonshotScore v2 | 91 of 100 · Exceptional · pillars 90 / 72 / 58 / 96 / 69 | OURS | Stock Expert AI MoonshotScore v2 engine | |
ours.moonshot_change | MoonshotScore movement | 91 (stored snapshot Oct 3, 2026) → 91 (current publication computed Oct 4, 2026) (0) | OURS | Stock Expert AI current score publication and immutable score snapshots — The current score publication is not yet represented in the immutable snapshot archive. |
Fact-family notes
- Quarterly statement note. Source series as of 2026-07-31. USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow. Applies to Fact IDs:
fin.q_table.depth.2026-07-31.revenue_k,fin.q_table.depth.2026-07-31.rd_k,fin.q_table.depth.2026-07-31.sga_k,fin.q_table.depth.2026-07-31.operating_result_k,fin.q_table.depth.2026-04-30.revenue_k,fin.q_table.depth.2026-04-30.rd_k,fin.q_table.depth.2026-04-30.sga_k,fin.q_table.depth.2026-04-30.operating_result_k,fin.q_table.depth.2026-01-31.revenue_k,fin.q_table.depth.2026-01-31.rd_k,fin.q_table.depth.2026-01-31.sga_k,fin.q_table.depth.2026-01-31.operating_result_k,fin.q_table.depth.2025-10-31.revenue_k,fin.q_table.depth.2025-10-31.rd_k,fin.q_table.depth.2025-10-31.sga_k,fin.q_table.depth.2025-10-31.operating_result_k. - Earnings-history note. Source series as of 2026-08-27. Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined. Applies to Fact IDs:
earn.history.depth.2026-08-27.revenue_actual,earn.history.depth.2026-08-27.revenue_estimated,earn.history.depth.2026-08-27.revenue_actual.comparison,earn.history.depth.2026-08-27.eps_actual.comparison,earn.history.depth.2026-08-27.eps_actual,earn.history.depth.2026-08-27.eps_estimated,earn.history.depth.2026-05-28.revenue_actual,earn.history.depth.2026-05-28.revenue_estimated,earn.history.depth.2026-05-28.eps_actual,earn.history.depth.2026-05-28.eps_estimated,earn.history.depth.2026-03-17.revenue_actual,earn.history.depth.2026-03-17.revenue_estimated,earn.history.depth.2026-03-17.eps_actual,earn.history.depth.2026-03-17.eps_estimated,earn.history.depth.2025-12-03.revenue_actual,earn.history.depth.2025-12-03.revenue_estimated,earn.history.depth.2025-12-03.eps_actual,earn.history.depth.2025-12-03.eps_estimated. - Cash-flow note. Source series as of 2026-07-31. USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway. Applies to Fact IDs:
fin.opcf.depth.2026-07-31.operating_cash_flow_m,fin.opcf.depth.2026-04-30.operating_cash_flow_m,fin.opcf.depth.2026-07-31.capex_m,fin.opcf.depth.2026-04-30.capex_m,fin.opcf.depth.2026-01-31.operating_cash_flow_m,fin.opcf.depth.2026-01-31.capex_m,fin.opcf.depth.2025-10-31.operating_cash_flow_m,fin.opcf.depth.2025-10-31.capex_m.
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources used for research written 2026-09-13
Historical evidence preserved with this analysis. Current figures are listed separately above.
| Evidence | Captured value | Source date | Source type | Source |
|---|---|---|---|---|
| Business description | Headquartered in Draper, Utah, and established in 2002, HealthEquity, Inc. furnishes technology-powered service platforms to both individual consumers and employers across the United States. The company provides cloud-based solutions designed to assist individuals in overseeing their healthcare expenditures and savings. These platforms enable users to make informed decisions about their health finances, pay medical bills, compare treatment options and costs, access personalized benefits and clinical data, earn incentives for wellness, and grow their savings through various investment avenues, including specific investment choices. In addition to these personal financial management tools, HealthEquity administers a range of health-related accounts, such as Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs). Its offerings also encompass a mutual fund investment platform, an automated online advisory service known as Advisor, COBRA continuation services, and the management of pre-tax commuter benefits programs. HealthEquity markets its services through a dedicated direct sales team, collaborates with benefits brokers and advisors, and leverages a comprehensive network comprising health plans, benefits administrators, consultants, and retirement plan record-keepers. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) company profile |
| Revenue by segment | Service: $485.02M; Credit and Debit Card: $191.61M; Financial Service, Other: $636.80M | 2026-01-31 | FMP | Financial Modeling Prep (FMP) revenue segmentation, from the company's 10-K |
| Annual revenue and net result (USD millions) | Captured record · 5 entries
| 2026-01-31 | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements |
| Operating cash flow by quarter (USD millions) | Captured record · 8 entries
| 2026-07-31 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements |
| Cash, investments and debt | Total debt: $971.02M; Liquidity basis: cash and short-term investments; Total liabilities: $1.28B; Cash and short-term investments: $256.00M; Cash and investments: $256.00M; Long-term investments: $0; Long-term investments classification: unclassified Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | 2026-07-31 | FMP | Financial Modeling Prep (FMP), from the company's balance sheet |
| Management outlook — dated call excerpts | Captured record · 4 entries
Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | 2026-08-27 | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) |
| Sector / industry (provider taxonomy) | Healthcare / Medical - Healthcare Information Services The company's SEC filings classify it under SIC 7389 — Services-Business Services, NEC. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) company profile |
| Quarterly income statement (USD thousands) | Captured record · 8 entries
| 2026-07-31 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements |
| Reported versus estimated, last 8 quarters | Captured record · 8 entries
| 2026-08-27 | FMP | Financial Modeling Prep (FMP) earnings |
| Analyst revenue and earnings estimates (average) | Captured record · 4 entries
| 2026-09-13 | FMP | Financial Modeling Prep (FMP) analyst estimates |
| Cash and investment components | Total basis: cash short and long-term investments; Total: $256.00M; Cash and short-term investments: $256.00M; Long-term investments: $0; Long-term investments classification: unclassified Sums the balance sheet's cash and short-term investments with its long-term investments.; The long-term investment field does not establish marketability; the sum is not a measure of available liquidity.; These provider fields do not establish investment access restrictions or explain differences from third-party cash figures. | 2026-07-31 | COMPUTED | Computed from the balance sheet |
| Cash and short-term investments over time (USD millions) | Captured record · 8 entries
| 2026-07-31 | FMP | Financial Modeling Prep (FMP), from the company's quarterly balance sheets |
| Cash decline over the reported window | To: 2026-07-31; From: 2024-10-31; Periods: 7; Cash basis: cash and short-term investments; Closing balance: $256.00M; Decline: $66.20M; Opening balance: $322.20M; Average change per period: $9.50M Change in cash, cash equivalents and short-term investments between the 2024-10-31 and 2026-07-31 balance sheets.; This is a balance change, not operating burn: financing and investing move it too.; Averaged over 7 reporting periods of unequal length. | 2026-07-31 | COMPUTED | Computed from reported balances |
| Cash against market value | As of: 2026-07-31; Cash basis: cash and short-term investments; Net cash: -$715.00M; Total debt: $971.00M; Cash and investments: $256.00M Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. Cash is the latest reported cash and short-term investment balance; long-term investments are excluded. Market capitalization is the latest provider value.; The reported balance does not establish unrestricted availability or liquidation value.; The two are measured on different dates — the balance sheet is a quarter-end, the market cap is a recent close.; Debt is total debt as reported, including operating lease liabilities where the filer includes them. | 2026-07-31 | COMPUTED | Computed from the balance sheet and the latest market capitalization |
| Trailing twelve-month ratio set | Quick ratio: 2.99; Current ratio: 2.99; Debt to equity: 0.49; Net margin: 17.4%; Gross margin: 75.2%; Operating margin: 25.6%; Return on assets: 7.2%; Return on equity: 11.4% Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. A ratio our provider could not compute is absent rather than shown as zero. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm |
| Distress and quality screens | Altman Z-score: 4.71; Piotroski F-score: 8 Altman Z below 1.8 is the conventional distress zone. The screen is built for manufacturers and industrials; for banks, insurers and property companies it is not a meaningful reading. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) financial scores |
| Next earnings report | Date: 2026-12-02; EPS estimate: $1.16 per share; Revenue estimate: $347.18M The date is our provider's estimate until the company confirms it. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) earnings calendar |
Data provided for informational purposes only.